FDA Panel: Restrict Some Top Asthma Drugs
Experts Say Risks Of Using Foradil, Serevent Outweigh Benefits; Advair OK
-
Photo
(AP / CBS)
-
Play CBS Video
Video
Recognizing Asthma Symptoms
More and more people each year are diagnosed with asthma, although some of the symptoms may be hard to detect. Dr. Mallika Marshall discusses some of the key triggers of asthmatic symptoms.
-
Video
Asthma Inhalers Going Green
By the end of the year, 22 million Americans who suffer from asthma will have to switch to a new, environmentally-friendly type of inhaler. Dr. Emily Senay reports.
-
Video
Suicide Linked To Singulair?
Singulair, the popular asthma and allergy drug, is under investigation by the FDA for a possible link to suicide. Kelly Wallace reports.
-
Quiz
Rx For Safe Medicines
Medicines: How Savvy Are You?
Outside experts advising the Food and Drug Administration recommended that Foradil and Serevent no longer be used for asthma. But they said the benefits of Advair and Symbicort clearly outweigh the risks.
All the medications contain an ingredient, known as a long acting bronchodilator, that relaxes muscles around stressed airways, reports CBS News Medical Correspondent Dr. Jon LaPook. But that may mask symptoms that can trigger life-threatening asthma attacks.
Advair and Symbicort contain a second ingredient, a steroid, that reduces inflammation inside breathing passages and may help patients avoid such problems.
Serevent and Foradil do not, and experts fear that they may they may cause patients to overdose or delay treatment.
"The concern for these drugs is that they may actually worsen asthma," Dr. John Jenkins, director of the FDA's Office of New Drugs told LaPook. "Rarely, in some patients, to the point some patients have died."
The FDA's own drug safety experts had recommended restrictions on all four drugs, including that none of them be used to treat asthmatic children. But the agency's respiratory specialists said the risks were manageable and no curbs were needed.
With its own experts deadlocked, the FDA called in an unusually large panel of 27 outside advisers. The medical and scientific experts said Advair and Symbicort should continue to be used with all patients, including children. The vote on Advair was 27-0; on Symbicort it was 26-0. On Foradil nine voted "yes" and 18 said "no," with a "no" vote meaning the risks were greater than the benefits. For Serevent the vote was 10-17.
The FDA usually follows the recommendations of its outside experts.
About 22 million people in the United States suffer from asthma, which claims nearly 3,600 lives. Children account for nearly one out of every three patients. An FDA analysis showed that the risks of long-acting asthma medications, though rare, were greater in children.
The four medications contain a kind of drug called a long-acting beta agonist, or LABA. It relaxes the muscles around stressed airways to help patients breathe.
But medical treatment guidelines say people with asthma should use a LABA together with a steroid to relieve inflammation within the airways. Advair and Symbicort combine both kinds of medicine in one inhaler. But Foradil and Symbicort are LABA-only medications.
In recent years, millions of asthma patients have turned to the long-acting drugs to help them breathe more normally, allowing adults to get nights of uninterrupted sleep, and kids, for instance, to join a soccer team. Advair dominates the market, with almost 4 million patients.
But in rare cases, the drugs can increase the risk of serious asthma complications and send patients to the emergency room gasping for air.
Some experts believe that using a LABA alone can mask developing symptoms, and unexpectedly get patients in trouble. That's why treatment guidelines call for LABA medications to be used with a steroid. Asthma patients also carry a "rescue" inhaler for emergencies.
About 22 million people in the United States suffer from asthma. Children account for nearly one out of every three patients. An FDA analysis showed that the risks of long-acting asthma medications, though rare, were greater in children.
"If this drug is removed from asthma treatment it would be a disaster," said Dr. Stanley Szefler of National Jewish Health, a Denver health system with a national reputation for respiratory care. He spoke on behalf of the American Academy of Allergy, Asthma and Immunology. Other medical societies voiced similar sentiments.
Baltimore-area teacher Anne Dorsey came to the meeting with her son Julian, 13, who has severe asthma. The mother told the panel that Julian nearly died from an asthma attack in 2006. But he has done much better since then, after he started taking Advair.
"I've spent a lot of time in the hospital," Julian said. "But when I took Advair, life got a whole lot easier."
Julian will be able to continue taking Advair. Patients taking either Serevent or Foradil should talk to their doctors.
"I think it would be a big mistake for somebody who is currently on these medications to stop the medications without consulting their physician," Columbia University Medical Center's Dr. Meyer Kattan told LaPook.
In preparation for the meeting, the FDA analyzed findings from 110 clinical trials involving nearly 61,000 patients, comparing patients who took a medication containing a LABA with those who used a steroid alone to control their asthma. Experts looked for deaths, hospitalizations and cases in which a patient had to have a breathing tube inserted.
The analysis found 20 deaths from asthma complications, of which 16 were in patients taking a LABA-only drug, Serevent.
Advair, made by GlaxoSmithKline, did not appear to have a higher rate of serious complications when compared with treatment on steroids only. Foradil, Serevent and Symbicort all had higher rates of problems, but the increase was statistically significant only in the case of Serevent.
Serevent is also made by Glaxo. Foradil is made by Novartis and Symbicort by AstraZeneca. That company disputed the FDA's analysis of Symbicort, saying the agency only considered a small slice of available data.
© MMVIII, CBS Interactive Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.



If you start to take Advair & body cramps should start. Call your doctor at once & stop taking it.
Has Dr. Hahn also warned you of the over use of antibiotics. Axithromax is a medication also given to HIV and AIDS patients to help them fight off infections due to their compromised immune system. Any asthmatic realizes that a cold, virus, flu, etc. can cause their asthma to flair up. When this happens an antibiotic may be necessary, but asthma is a disease and should be treated accordingly. The fact that you are not allowing your child to be treated accordingly is a huge injustice. Asthma needs to be treated properly so the lungs are not damaged any more that they already are.